PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Beijing North Institute of Biotechnology Co., Ltd., NO. A20 Panjiamiao, Fengtai Distrct, Beijing, China. Electronic address: xzs_duanxuejun@163.com.\', \'Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, China.\', \'Beijing North Institute of Biotechnology Co., Ltd., NO. A20 Panjiamiao, Fengtai Distrct, Beijing, China.\', \'Beijing Institute of Brain Disorders, Capital Medical Univerity, Beijing, China.\', \'Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital, Capital Medical University, Beijing, China; NMPA Key Laboratory for Quality Control of In Vitro Diagnostics, Beijing, China; Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing, China. Electronic address: tiantanzgj@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0956-5663(21)00920-910.1016/j.bios.2021.113883
?:hasPublicationType
?:journal
  • Biosensors & bioelectronics
is ?:pmid of
?:pmid
?:pmid
  • 34942543
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all